FITLIFE BRANDS, INC.

FTLF ·Healthcare, Drug Manufacturers - General, United States
Financial Statements Cash Flow Statement
Annual Quarterly

Cash Flow Statement

Line Item FY2025 FY2024 FY2023 FY2022 FY2021 FY2020 FY2019 FY2018
Operating Activities
Net Income $6.3M $9.0M $5.3M $4.4M $5.4M $8.8M $2.6M $509.0K
Depreciation & Amortization $420.0K $108.0K $94.0K $66.0K $59.0K $38.0K $52.0K $69.0K
Depreciation $73.0K $70.0K $52.0K $24.0K $28.0K $38.0K $52.0K
Amortization $347.0K $38.0K $42.0K $42.0K
Stock-Based Compensation $29.0K $118.0K $130.0K
Net Cash from Operating Activities $7.4M $9.6M $4.2M $4.1M $4.5M $5.7M $2.3M $258.0K
Investing Activities
Capital Expenditures $42.0K $10.0K $106.0K $0 $0
Business Acquisitions $0 $529.0K $0
Net Cash from Investing Activities $-42.5M $-10.0K $-36.0M $0 $-529.0K $0 $0 $4.0K
Financing Activities
Dividends Paid $0 $63.0K $0
Stock Repurchases $0 $779.0K $444.0K $171.0K $1.5M $0
Net Cash from Financing Activities $32.1M $-7.0M $20.3M $-750.0K $-390.0K $350.0K $-2.3M $-1.3M
Net Change in Cash $-2.9M $2.6M $-11.4M $3.4M $3.6M $6.1M $6.0K $-1.0M
Free Cash Flow $7.4M $9.6M $4.1M $4.1M $258.0K
← Newer Page 1 of 2 Older →